{"id":153851,"date":"2023-11-30T10:46:23","date_gmt":"2023-11-30T17:46:23","guid":{"rendered":"https:\/\/www.globaldownsyndrome.org\/?p=153851"},"modified":"2026-06-29T14:43:59","modified_gmt":"2026-06-29T20:43:59","slug":"global-announces-authors-for-new-edition-of-1st-evidence-based-global-medical-care-guidelines-or-adults-with-down-syndrome","status":"publish","type":"post","link":"https:\/\/www.globaldownsyndrome.org\/es\/global-announces-authors-for-new-edition-of-1st-evidence-based-global-medical-care-guidelines-or-adults-with-down-syndrome\/","title":{"rendered":"GLOBAL Announces Authors for New Edition of 1st Evidence-Based GLOBAL Medical Care Guidelines or Adults with Down Syndrome"},"content":{"rendered":"

Sleep Apnea, Eye\/Vision Care, Solid Tumors, Leukemia, and Physical Therapy Additions are Planned for Second Edition in 2027<\/span><\/i><\/span><\/p>\n

DENVER \u2013November 30, 2023 <\/strong>-<\/p>\n

Today, Fundaci\u00f3n Mundial del S\u00edndrome de Down<\/a> announced the roster of authors for the second edition of the first evidence-based GLOBAL Medical Care Guidelines for Adults with Down Syndrome (\u201cGLOBAL Adult Guideline\u201d). The first edition was published in JAMA<\/em><\/a>El Journal of American Medical Association,<\/em> in October 2020, and is comprised of free checklists\/toolkits, a family-friendly version, and translations into Spanish and Japanese. The fifteen authors include Down syndrome experts and the directors of the largest adult Down syndrome clinics in the U.S. Global Down Syndrome Foundation (\u201cGLOBAL\u201d) has also recruited an additional twenty volunteer committee members representing additional Down syndrome medical expertise.<\/p>\n

The GLOBAL Adult Guideline Second Edition will provide new and important clinician guidance in the areas of sleep apnea, eye\/vision care, solid tumors, leukemia, and physical therapy and fitness. The nine medical topics covered in the first edition will also be updated: behavior, dementia, diabetes, cardiovascular disease, obesity, osteoporosis, atlantoaxial instability, thyroid disease, and celiac disease. GLOBAL, along with an impressive International Advisory Committee, is working to ensure that a family-friendly version, checklists\/toolkits, and multiple language versions will be published shortly thereafter.<\/p>\n

\"Atlantoaxial<\/p>\n

\u201cWe are so pleased to be able to expand this important resource for our adults with Down syndrome,\u201d says Bryn Gelaro, Senior Director of Research & Medical Care at GLOBAL. \u201cThe work can be very difficult given the lack of historical research but creating a 5-6 year cycle where we can dependably update new editions of this guideline is so rewarding. It is also an honor to be working with our brilliant authors and medical committee members.\u201d<\/p>\n

The Authors in Alphabetical Order:<\/p>\n

    \n
  1. Peter Bulova, MD<\/u> – Professor of Medicine; Medical Director, University of Pittsburgh Adult Down Syndrome Center; Co-Director, Magee Center for Women with Disabilities, University of Pittsburgh Department of Medicine, Pittsburg, PA<\/li>\n
  2. George Capone, MD<\/u> – Associate Professor of Pediatrics; Director, Down Syndrome Clinic and Research Center, Medical Director, Pediatric Feeding Disorders Program, Kennedy Krieger Institute, Baltimore, MD<\/li>\n
  3. Brian Chicoine, MD<\/u> – Medical Director and Co-Founder, Advocate Medical Group Adult Down Syndrome Center, Park Ridge, IL<\/li>\n
  4. Joaqu\u00edn Espinosa, PhD<\/u> – Executive Director, Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO<\/li>\n
  5. Terry Harville, MD, PhD, D(ABMLI), D(ABHI)<\/u> – Professor of Internal Medicine, in the Division of Hematology\/Oncology; Medical Director, HLA and Histocompatibility Laboratory; Medical Director, Immunogenetics and Transplantation Laboratory, University of Arkansas for Medical Sciences, Little Rock, AR<\/li>\n
  6. Christine Heubi, MD<\/u> – Surgical Director,\u00a0Complex Obstructive Sleep Apnea Center; Assistant Professor,\u00a0UC Department of Otolaryngology, Head and Neck Surgery, University of Cincinnati, Cincinnati, OH<\/li>\n
  7. Vishal Jhanji, MD <\/u>– Professor of Ophthalmology at the University of Pittsburgh School of Medicine, University of Pittsburg Department of Ophthalmology Pittsburgh, PA<\/li>\n
  8. Barry Martin, MD<\/u> – Associate Professor of General Internal Medicine, University of Colorado School of Medicine; Medical Director, Adult Down Syndrome Clinic at Denver Health, Denver, CO<\/li>\n
  9. Emily McCourt, MD<\/u> – Chief of Pediatric Ophthalmology; Vice Chair of Pediatric Ophthalmology; The Ponzio Family Chair for Pediatric Ophthalmology, Children\u2019s Hospital Colorado, Aurora, CO<\/li>\n
  10. Lina Patel, PsyD<\/u> – Associate Professor, Department of Psychiatry; Director of the Down Syndrome Behavioral Health Collaborative, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO<\/li>\n
  11. Moya Peterson, PhD, ARNP<\/u> – Clinical Professor, School of Nursing; Co-founder and Medical Director, Adults with Down Syndrome Specialty Clinic, University of Kansas Medical Center,<\/li>\n
  12. Michael Puente Jr, MD<\/u> – Assistant Professor, Ophthalmology, School of Medicine, University of Colorado Anschutz Medical Campus; Director of Medical Student Education, Aurora, CO<\/li>\n
  13. Mike Rafii, MD, PhD<\/u> – Professor of Clinical Neurology; Medical Director of the Alzheimer\u2019s Therapeutic Research Institute; Alzheimer\u2019s Clinical Trials Consortium \u2013 Down Syndrome Principal Investigator, Keck School of Medicine of University of Southern California, Los Angeles, CA<\/li>\n
  14. Carl Tyler, MD<\/u> – Professor of Family and Community Medicine at Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine; Executive Board, American Academy of Developmental Medicine and Dentistry, Cleveland, OH<\/li>\n
  15. Anna Marie White, MD, FACP, FAAP<\/u> – Clinical Assistant Professor of Medicine and Pediatrics; Medical Director, Street Medicine Pitt, University of Pittsburgh Medical Center, Pittsburgh, PA<\/li>\n<\/ol>\n

    GLOBAL has worked with Congress and the National Institutes of Health (NIH) since 2006 advocating for a trans-NIH Down syndrome research funding program and for increased funding. In December of 2010, GLOBAL and the NIH co-organized the first Down syndrome research conference with a focus on registries and biobanks. One important result was the establishment of DS-Connect\u00ae: El Registro del S\u00edndrome de Down<\/a> at the Eunice Kennedy Shriver<\/em> National Institute of Child Health and Human Development (NICHD).<\/p>\n

    GLOBAL has published both an 80-page guideline for medical professionals and a family-friendly version in Spanish in collaboration with El Centro de la Universidad Cat\u00f3lica de S\u00edndrome de Down in Chile and in Japanese in collaboration with the Japan Down Syndrome Association.<\/p>\n

    Para obtener m\u00e1s informaci\u00f3n sobre la Gu\u00eda Mundial del Adulto y descargar su ejemplar hoy mismo, visite <\/em>www.globaldownsyndrome.org\/medical-care-guidelines-for-adults\/<\/em><\/a><\/p>\n

    Para m\u00e1s informaci\u00f3n sobre la Fundaci\u00f3n Global S\u00edndrome de Down, visite<\/em> www.globaldownsyndrome.org<\/em><\/a><\/p>\n

     <\/p>\n

    # # #<\/p>\n

    Acerca de la Fundaci\u00f3n Global S\u00edndrome de Down<\/strong><\/p>\n

    The Global Down Syndrome Foundation (GLOBAL) is the largest non-profit in the U.S. working to save lives and dramatically improve health outcomes for people with Down syndrome. GLOBAL has donated more than $32 million to establish the first Down syndrome research institute supporting over 400 scientists and over 2,400 patients with Down syndrome from 33 states and 10 countries. Working closely with Congress and the National Institutes of Health, GLOBAL is the lead advocacy organization in the U.S. for Down syndrome research and care. GLOBAL has a membership of over 100 Down syndrome organizations worldwide, and is part of a network of Affiliates \u2013 the\u202fInstituto Crnic para el S\u00edndrome de Down<\/a>ElCentro Sie para el s\u00edndrome de Down<\/a>y elCentro de Alzheimer y Cognici\u00f3n de la Universidad de Colorado<\/a>- todo ello en el Anschutz Medical Campus.<\/p>\n

    Entre las publicaciones m\u00e9dicas de GLOBAL de mayor difusi\u00f3n figuranGu\u00eda global de cuidados m\u00e9dicos para adultos con s\u00edndrome de Down<\/em><\/a>,Informaci\u00f3n prenatal y neonatal sobre el s\u00edndrome de Down<\/em><\/a> y la galardonada revistaEl mundo del s\u00edndrome de DownTM<\/sup><\/em><\/a>. GLOBAL tambi\u00e9n organiza elDesfile de moda Be Beautiful Be Yourself<\/em><\/a>la mayor recaudaci\u00f3n de fondos para el s\u00edndrome de Down del mundo. Visita globaldownsyndrome.org y s\u00edguenos en las redes sociales (Facebook y Twitter: @GDSFoundation, Instagram: @globaldownsyndrome).<\/p>\n

    AVISO IMPORTANTE<\/strong><\/p>\n

    Aunque el contenido de este comunicado de prensa y de las Directrices GLOBAL ha sido desarrollado por GLOBAL y los autores de las Directrices GLOBAL, no podemos ni pretendemos ofrecer asesoramiento m\u00e9dico o jur\u00eddico a las personas. Por favor, p\u00f3ngase en contacto con su(s) m\u00e9dico(s) o asesor(es) legal(es) para preguntas espec\u00edficas sobre su historial m\u00e9dico o cuidados individuales.<\/p>\n

    Press Contact<\/strong><\/p>\n

    Anca Call: acall@globaldownsyndrome.org<\/a>, 720-320-3832<\/p>\n

     <\/p>\n

     <\/p>","protected":false},"excerpt":{"rendered":"

    Sleep Apnea, Eye\/Vision Care, Solid Tumors, Leukemia, and Physical Therapy Additions are Planned for Second Edition in 2027 DENVER \u2013November 30, 2023 \u2013 Today, Global Down Syndrome Foundation announced the roster of authors for the second edition of the first evidence-based GLOBAL Medical Care Guidelines for Adults with Down Syndrome (\u201cGLOBAL Adult Guideline\u201d). The first […]<\/p>\n","protected":false},"author":3,"featured_media":153852,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"ngg_post_thumbnail":0,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-153851","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-releases"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t